Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs.
Financial Results:
Jubilant Pharmova Ltd reported Revenues for Q3FY24 of ₹1,677.00 Crores up from ₹1,552.00 Crore year on year, a rise of 8.05%.
Total Expenses for Q3FY24 of ₹1,625.00 Crores up from ₹1,553.00 Crores year on year, a rise of 4.64%.
Consolidated Net Profit of ₹66.00 Crores from -₹16.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹4.19, from -₹0.98 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.